GlassScriptPhysician profile
Xiaowen Guo
NPI 1851778963
$5,065.27
in general payments reported to CMS, 2019-2025
38 companies · $834 in 2025
The $834 reported for 2025 was more than what 82% of Adult Health (Nurse Practitioner) providers received nationally (typical 2025 total: $182).
See the full distribution for Adult Health (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,009 · 2022: $1,051 · 2023: $1,046 · 2024: $1,127 · 2025: $834.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,981 · Education: $25.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,980.70 |
| Education | $25.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $967.23 | 2021-2025 | |
| Lilly USA, LLC | $734.60 | 2021-2025 | Mounjaro, Zepbound, Jardiance |
| Novo Nordisk INC | $422.46 | 2021-2025 | Wegovy, Ozempic |
| Exact Sciences Corporation | $246.49 | 2023-2025 | Cologuard Collection Kit |
| Abbott Laboratories | $243.59 | 2023-2024 | Freestyle Libre 3 |
| Biohaven Pharmaceuticals, INC. | $238.74 | 2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $196.30 | 2022-2025 | |
| Astrazeneca Pharmaceuticals LP | $177.74 | 2021-2024 | Farxiga, Airsupra |
| Sanofi-Aventis U.S. LLC | $168.76 | 2021-2025 | |
| Dexcom, INC. | $162.64 | 2023-2025 | Dexcom G6 Transmitter |
| Biohaven Pharmaceutical Holding Company LTD. | $139.41 | 2022 | |
| Corcept Therapeutics | $124.32 | 2024 | Korlym |
| Inspire Medical Systems, INC. | $118.52 | 2024 | Inspire |
| Verity Pharmaceuticals INC. | $106.97 | 2024-2025 | Tlando |
| Antares Pharma, INC. | $91.54 | 2021-2023 | Nocdurna, Tlando, Xyosted |
Show all 38 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Xiaowen Guo listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.